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Abstract
Background: The diagnostic ability of computer-based methods for cardiovascular system (CVS) monitoring offers
significant clinical potential. This research tests the clinical applicability of a newly improved computer-based
method for the proof of concept case of tracking changes in important hemodynamic indices due to the influence
acute pulmonary embolism (APE).
Methods: Hemodynamic measurements from a porcine model of APE were used to validate the method. Of these
measurements, only those that are clinically available or inferable were used in to identify pig-specific computer
models of the CVS, including the aortic and pulmonary artery pressure, stroke volume, heart rate, global end
diastolic volume, and mitral and tricuspid valve closure times. Changes in the computer-derived parameters were
analyzed and compared with experimental metrics and clinical indices to assess the clinical applicability of the
technique and its ability to track the disease state.
Results: The subject-specific computer models accurately captured the increase in pulmonary resistance (Rpul), the
main cardiovascular consequence of APE, in all five pigs trials, which related well (R2 = 0.81) with the
experimentally derived pulmonary vascular resistance. An increase in right ventricular contractility was identified, as
expected, consistent with known reflex responses to APE. Furthermore, the modeled right ventricular expansion
index (the ratio of right to left ventricular end diastolic volumes) closely followed the trends seen in the measured
data (R2 = 0.92) used for validation, with sharp increases seen in the metric for the two pigs in a near-death state.
These results show that the pig-specific models are capable of tracking disease-dependent changes in pulmonary
resistance (afterload), right ventricular contractility (inotropy), and ventricular loading (preload) during induced APE.
Continuous, accurate estimation of these fundamental metrics of cardiovascular status can help to assist clinicians
with diagnosis, monitoring, and therapy-based decisions in an intensive care environment. Furthermore, because
the method only uses measurements already available in the ICU, it can be implemented with no added risk to
the patient and little extra cost.
Conclusions: This computer-based monitoring method shows potential for real-time, continuous diagnosis and
monitoring of acute CVS dysfunction in critically ill patients.
Background
Traditional hemodynamic monitoring in critical care is
constrained by the ease and frequency at which mea-
surements can be made and taken. The use, number,
and positioning of catheters is determined by the
perceived risk-to-benefit ratio of inserting the device(s).
Hence, catheters cannot always be placed in the most
ideal position for monitoring a certain pathological
state. Other factors, including expense and obstruction
to clinical work flow, limit the regularity at which other
measurements are taken, such as with the use of com-
puter tomography and echocardiography. Due to these
constraints, clinicians often do not receive a full picture
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of a patient’s hemodynamic state, which can result in
misdiagnosis and incorrect treatment, leading to ineffi-
cient use of hospital resources, increased length of stay,
and death [1-5]. Integration of all available measure-
ments in a mathematical framework of cardiovascular
physiology could be employed to predict cardiac and
circulatory status continuously in regions that cannot be
directly measured. Such a method would provide a
means to untangle the complex, often confusing interac-
tions that occur between different measurements to bet-
ter reveal a patient’s underlying disease state, and
therefore, maximize the useful information gained.
It has been proposed, and proven with glycemic con-
trol [6-8] and in other fields [9-12], that computer-
based models can be used to assist medical staff with
therapy-based decisions. For a model-based method to
be clinically viable for hemodynamic monitoring in clin-
ical practice it should:
• Accurately predict static markers of the cardiovascu-
lar health,
• Track pathologically important hemodynamic trends,
• Track the effectiveness of treatment,
• Be inexpensive and easy to implement,
• Provide continuous real-time feedback,
• Be an improvement on current hemodynamic moni-
toring methods.
If these points can be achieved, a better understanding
of the patient’s disease state can be obtained without
added cost or invasive measurements, and the effective-
ness of treatment can be monitored with greater accu-
racy, ultimately leading to improved outcome. A flow
chart illustrating the proposed role of a model-based
method in intensive care unit (ICU) is shown in Figure 1.
Previously, a mathematical model of the cardiovascu-
lar system (CVS) has been validated in different cardiac
and circulatory states [13-16] and a method of persona-
lizing the model from hemodynamic measurements had
been created [17-20]. However, this method lacked clini-
cal applicability for several reasons:
1) It required knowledge of the left and right ventricu-
lar volume waveforms
2) It was too slow to give real-time information
3) Either knowledge of the left and right ventricular
pressure waveforms were required or population-based
assumptions were needed to identify the valvular
resistances
Hence, to truly individualize a computer model of the
CVS to each patient, highly invasive or expensive mea-
surements of the left and right ventricle’s were required,
limiting the clinical use of this method.
This paper presents initial results from a newly
developed method [21,22], in which subject-specific
modes of the cardiovascular system are identified from
typically available ICU measurements. The object of
the research was to test the accuracy and clinical
applicability of this technology, with data from a pre-
vious study by Ghuysen et al. [23], before it is tested
in human trials. This retrospective, proof of concept
animal study uses measurements obtained from five
porcine trials where acute pulmonary embolism (APE)
was induced. The method has already been shown to
predict static markers of CVS health, but its ability to
Figure 1 Proposed usage of model-based monitoring techniques.
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monitor pathologically induced trends has not been
assessed.
Hence, the goal of the paper was to assess the ability
of the computer model to track clinically relevant hemo-
dynamic changes resulting from APE. Changes in the
model parameters are compared to clinically expected
trends from the literature, experimentally derived
metrics, and measured data, to test the ability of the
model to track cardiovascular changes resulting from
APE [23-25]. The overall goal was to demonstrate the
clinical relevance and prove the concept (and potential)
of model-based clinical monitoring of CVS status and
acute dysfunction.
Methods
A computer-based hemodynamic monitoring technique
was retrospectively tested using measurements from a
porcine model of APE. In this research, a mathematical
model acts as framework to which metrics of cardiac
and circulatory state can be personalized to describe the
subject particular hemodynamic state. The CVS model
is individualized to each pig using a model identification
method, which matches the model to cardiovascular
measurements form porcine trials. The pig-specific
models are then compared to measurements not used to
identify the models and experimentally derived indices
to assess their accuracy and clinical potential.
Cardiovascular system model
A lumped parameter model of CVS has been previously
validated [13-16,19]. In this type of model the “lumped”
parameters describe the macrodynamics of large sec-
tions of the CVS, instead of small localized effects. For
example, the model parameter, systemic vascular resis-
tance, represents the combined effects of the resistance
of the all the vessels in the body, whereas localized dif-
ferences in the resistance of small sections of the vascu-
lature are not modeled. The lumped nature allows the
model to be relatively simple, requiring only a small
number of parameters, yet complex enough to describe
all the important global hemodynamics of the CVS.
The CVS model consists of six elastic pressure-volume
chambers representing the left and right ventricles,
aorta, vena cava, pulmonary artery, and pulmonary vein
(Figure 2). Myocardium activation is modeled using
time varying elastance in the left and right ventricle
chambers, which act as the pumps for the model. In
other words, time-varying elastance acts as a way of
modeling the active increase in pressure in the ventricles
resulting from cardiac contraction. The other chambers
are passively elastic, and they react to changes in volume
by proportionally changing pressure. The flow between
chambers is controlled by a series of resistances. These
resistances define what the pressure differences between
adjacent chambers are for a given flow rate and physi-
cally describe how difficult it is to push blood through
certain parts of the CVS. Flow-gated inertial heart valves
close to avoid backwards flow and describe the inertial
effects of the fast-flowing blood through the valves.
Furthermore, the interdependence of the ventricles is
modeled through septum and pericardium dynamics.
The combination of these model features and para-
meters provide a means for accurately depicting ventri-
cular, arterial, and venous blood pressures and volumes,
and the blood flow rates through the heart valves, body,
and lungs. A full list of the model equations, parameters,
and outputs is given in the references [13-16,21].
Porcine experiments and data
All procedures and protocols used in the porcine experi-
ments were reviewed and approved by the Ethics Com-
mittee of the Medical Faculty at the University of Liege
(Belgium). Six pure pietrain pigs were premedicated and
anesthetized as described previously [23]. Throughout
the trials, 10 ml/kg volume-cycle ventilation was pro-
vided after endotracheal intubation at a respiratory rate
of 20 breaths per minute. Inspired oxygen fraction was
set to 40%, and the respiratory settings were adjusted to
maintain CO2 between 30 and 35 mmHg. Access to the
cardiac chambers and pulmonary truck was achieved via
median sternotomy. A micromanometer-tipped catheter
was inserted into the pulmonary artery through an inci-
sion in the right ventricle outflow track and was
adjusted to be 2 cm downstream from the pulmonary
valve. Another micromanometer-tipped catheter was
descended into the thoracic aorta through the femoral
artery. Furthermore, 7F, 12-electrode conductance,
micromanometer-tipped catheters were positioned in
the left and right ventricle so that all electrodes were
within these cavities.
To simulate APE, three autologous blood clots of
decreasing size (0.25, 0.125, and 0.0625 g kg-1) were
inserted into the external jugular vein at 0, 120, and 240
minutes into the trials. From the catheters, continuous
waveforms over 6 to 12 heartbeats were obtained every
30 minutes (T0 to T270) of left and right ventricular
pressures and volumes (Plv, Prv, Vlv, Vrv), aortic pressure
(Pao), and pulmonary artery pressure (Ppa). This research
uses 46 sets of data from five of the pigs (pig 1, pig 2,
pig 3, pig 4, and pig 5) from the study [23]. Measure-
ments from the sixth pig were omitted, because it died
very early in the trial.
Model identification
A new, more clinically applicable, model identification
method has been developed to replace the old approach
[17-20]. The new method only requires a minimal set of
discrete measurements, such as stroke volume and
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mean aortic pressure, that are easily obtainable in the
ICU. Whereas the previous method required measure-
ments of continuous waveforms, including the highly
invasive (or expensive) measures of the time varying
ventricular volume traces, which require a lot of compu-
tation processing. The measurements used by the new
approach are far fewer and far less intensive to obtain
and utilize. Thus, this study shows a significant step for-
ward in making this type of model-based approach
more clinically applicable and accessible without added
clinical effort or burden to the patient.
In this research, the model identification method uti-
lizes measurements from the porcine trials to match
CVS model to the pig’s specific hemodynamics. The
process uses only clinically available measurements from
trials to create the subject-specific models. In this
approach, the CVS model acts as a structure of cardiac
and circulatory physiology to which model parameters
are personalized. Model outputs are matched to a mini-
mal set of measurements, including features from the
aortic and pulmonary artery pressure waveforms, stroke
volume, heart rate, global end diastolic volume (GEDV),
Figure 2 Overview of the six-chamber cardiovascular model.
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and mitral and tricuspid valve closure times, all of which
are commonly available. For this research, GEDV was
assumed to be related to the sum of the left and right
ventricular end diastolic volumes (LVEDV, RVEDV) cal-
culated from Vlv and Vrv. Clinically, the features
required from the aortic pressure waveform, including
systolic pressure, diastolic pressure, and maximum pres-
sure gradient, can be inferred from radial artery pressure
waveform using methods described previously [26-31].
Furthermore, because only basic features are required
from the aortic and pulmonary artery pressure wave-
forms, high fidelity measurements are not required.
Hence, measurements from commonly used fluid-filled
catheters with frequency responses greater than 10 Hz
can be used with this approach.
The model identification process iteratively compares
the outputs from the CVS to corresponding measure-
ments from the minimal clinical data set to find better
approximations for the pig-specific parameters. Once
the model outputs match the measurement set, the pro-
cess outputs a CVS model with individualized para-
meters that describe the pig’s specific hemodynamics. A
full description of the model identification method can
be found in Revie et al. [22] for the interested reader.
Analysis
For this proof of concept study, the model identification
process was tested with 46 sets of porcine data from
five pigs with induced pulmonary embolism [23]. Rela-
tive percentage errors and accuracy and precision
indices derived from absolute errors were calculated.
The accuracy indices were derived by calculating the
mean of the absolute error of the model outputs for
each pig. The precision indices describe the 90th percen-
tile range of the absolute error of the model outputs for
each pig. The relative and absolute errors were calcu-
lated by comparing the measured LVEDV and REVDV,
and maximum left and right ventricular pressures to the
model outputs (Plv, Vlv, Prv, Vrv). These specific mea-
surements were taken experimentally, but critically, not
used to identify the CVS model. Hence, they represent
true, independent validation tests of the identified sub-
ject-specific model’s ability to capture the subject’s true
dynamics. These comparisons provide a first validation
of the subject-specific model’s ability to accurately
represent the subject at a specific point in time. Second,
verification of model convergence is checked by com-
paring the model outputs to the measured data used in
the identification process.
Finally, for proof of concept and clinical relevance, it
must be shown that the identified CVS models are cap-
able of tracking clinical metrics of APE as they evolve
through time. At each measurement time, the model
parameters that are directly related to APE are averaged
across the five pigs and compared with the same aver-
aged experimentally derived metric and measurements
from Ghuysen et al. [23] to calculate the Pearson corre-
lation coefficient (R2 value). This analysis shows that the
identified models (over time) capture clinically relevant
and observed diagnostic trends. It would thus, in combi-
nation with the other analyses, validate the clinical rele-
vance and concept of this model-based approach.
Please note that due to the small number of subjects
(n = 5 with usable measurements) in the study a more
in-depth statistical analysis could not be undertaken.
Hence, statistically significant changes in the model
parameters resulting from the insertion of emboli in the
pigs could not be quantified, because the sample size
was too small to calculate a clinically meaningful p
value.
Results
Physiological model validation
Measurements not used in the identification process,
were utilized post-identification to validate the accuracy
of the pig-specific models. Figures 3 and 4 show an
example of the personalised CVS model for pig 4 pre-
dicting the measured left and right ventricular volumes
and pressures (Plv, Vlv, Prv, Vrv) at different time points
during the trial. Median and 90th percentile errors were
calculated for the modeled mean aortic and pulmonary
artery pressures, LVEDV and RVEDV, and the maxi-
mum left and right ventricular pressures in each trial as
summarized in Table 1. Across all of the pigs, the mod-
eled LVEDV and RVEDV and the maximum left and
right ventricle pressures (Plv, Prv) lie within absolute
error ranges of 4.1% to 15.1%. Furthermore, accuracy
and precision metrics were calculated from the absolute
errors in the model estimated LVEDV, RVEDV, and
maximum Plv and Prv values. Noticeably, the errors are
largest for pigs 1 and 2. These two pigs died during the
trials with large drops in blood pressure and CO
observed before death. For example, the mean aortic
pressure and CO for pig 1 fall from baseline values of
92.4 mmHg and 2.3 L/min to 37.2 mmHg and 0.7 L/
min, respectively. These values fall below what is con-
sidered a survivable physiological range for pigs of this
size and result in low flow dynamics that cannot be
represented by the CVS model. Hence, the averaged
errors of Table 1, and the accuracy and precision
metrics of Table 2 are distorted by the model outputs
identified from the measurement sets recorded directly
before death in pigs 1 and 2.
Clinical proof of concept validation
The main effect of pulmonary embolism on the CVS is
a rise in pulmonary vascular resistance (PVR) or Rpul in
the model. Hence, monitoring the opposition to flow in
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the pulmonary circulation, available only via the model,
can give insight into diagnosing and tracking the pro-
gress of APE. Although Rpul is not the only component
of pulmonary afterload, it is the parameter in the model
that is most affected by direct mechanical obstruction to
the vasculature and has therefore been chosen for analy-
sis here. In all five trials an increase in Rpul is observed
(Figure 5). Averaged over all five pigs, Rpul compared
well to a pulmonary vascular resistance derived from a
windkessel model [23], which is a standard clinical
metric, with a correlation coefficient of R2 = 0.81. Figure
5 shows Rpul systemically overestimating the experimen-
tally derived PVR, but importantly, the modeled value
tracks the large increases in PVR at t120 and t240 after
pulmonary embolization. However, noticeable discrepan-
cies in the modeled and experimentally derived trends
are also visible in Figure 5, especially between T150 and
T210 and after T265 where the gradient between the
two traces are of opposite slope. These differences result
from difficulties in modeling the low flow states, directly
before death, in pig 1 (which dies after T270) and pig 2
(which dies after T180). Hence, the averaged Rpul values
at T180 and T270 have a larger error associated with
them, which account for some of the differences in the
slope. Another compounding factor is that after T180
only values from four pigs are averaged instead of five,
as pig 2 dies, which causes a slight distortion in mod-
eled Rpul trend at this point.
A direct cause of the sharp increase in PVR is acute
pulmonary hypertension. Consequentially, the systolic
right ventricular pressure must increase to push blood
through the pulmonary valve over the ejection cycle.
This result is seen in the pig-specific models (Figure
6), where large increases in the maximum right ventri-
cular pressures largely follow changes in Rpul from Fig-
ure 5. As with the modeled Rpul, the modeled Plv, max
systematically overestimates the experimental measure-
ments. However, more importantly, the general trend
is captured by the model to a high degree of accuracy
(R2 = 0.9).
The right ventricle adapts to increases in pressure by
dilating, because it is a compliant chamber. This dilation
Figure 3 Comparison of the modeled to measured left ventricular pressure waveform, volume waveform, and pressure-volume loops
for pig 4 at 30, 120, and 210 minutes into the trial. The dashed line shows the measured waveform and the solid line the CVS model
output.
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causes the right ventricle to bulge into the left ventricle
resulting in a leftward shift in the intraventricular sep-
tum, a known response of APE [32,33]. In the model
the right ventricle expansion index (RVEI), which is the
ratio of the RVEDV to LVEDV, is used to define the
magnitude of this shift. Figure 7 shows the comparison
of the modeled and measured averaged RVEI, where the
model again overestimates the measured metric but cap-
tures the overall trend. Here, the modeled ratio related
to the measured RVEI with a correlation coefficient of
R2 = 0.92. Interestingly, large increases in RVEI are
identified for pigs 1 and 2 that died during the trials.
Of further interest is how each pig’s CVS responds to
the insertion of emboli. In particular, how the right ven-
tricular contractility, Ees, rvf, reacts to the increased after-
load of the pulmonary circulation and how the systemic
Figure 4 Comparison of the modeled to measured right ventricular pressure waveform, volume waveform, and pressure-volume
loops for pig 4 at 30, 120, and 210 minutes into the trial. The dashed line shows the measured waveform and the solid line the CVS model
output.
Table 1 Median and 90th percentile absolute percentage
errors of the model outputs compared to measured data.
Output Error Pig 1 Pig 2 Pig 3 Pig 4 Pig 5 All
Pao, mean Median 0.2 0.1 0.2 0.1 0.1 0.1
90th 0.5 0.1 0.4 0.5 0.2 0.4
Ppa, mean Median 0.1 0.1 0.1 0.0 0.1 0.1
90th 0.5 0.1 0.1 0.1 0.1 0.4
LVEDV Median 3.3 18.2 4.3 2.5 1.9 4.1
90th 15.9 22.8 7.0 6.5 4.6 17.4
RVEDV Median 6.5 15.8 4.3 2.6 1.9 4.4
90th 14.6 18.9 7.4 7.0 6.9 15.3
Plv, max Median 11.4 9.2 2.7 1.5 1.7 2.1
90th 27.8 23.5 4.5 3.1 2.5 20.5
Prv, max Median 15.5 30.6 3.7 2.7 18.4 15.1
90th 18.3 31.6 15.6 5.7 23.3 27.2
Mean aortic and pulmonary artery pressures (Pao, mean Ppa, mean) are used in
the identification process, whereas the left and right ventricular volumes
(LVEDV, RVEDV), and maximum left and right ventricular pressures, (Plv, max,
Prv, max) were not for identification and are true validations
Table 2 Accuracy and precision of the estimated left and
right ventricular volumes (LVEDV, RVEDV), and maximum
left and right ventricular pressures (Plv, max Prv, max)
Output Error Pig 1 Pig 2 Pig 3 Pig 4 Pig 5
LVEDV (ml) Accuracy -2.1 -11.1 1.2 0.5 -0.8
Precision 8.7 9.6 7.1 5.8 3.5
RVEDV (ml) Accuracy 3.9 11.2 0.7 -0.4 2.6
Precision 9.8 9.1 6 5.9 3.5
Plv, max (mmHg) Accuracy -10 -16 3.6 0.8 2.2
Precision 20.9 18.1 4.5 5 3
Prv, max (mmHg) Accuracy 8.1 18.7 0.3 1.6 13.6
Precision 4.8 2.4 6.8 3.4 7
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resistances, Rsys, is altered to maintain the distribution of
blood in the CVS. These two reflex responses are shown
in Figure 8. The averaged Ees, rvf from the model is seen
to increase significantly after the insertion at T120 and
T240 and appears to track changes in Rpul from Figure
5. On the other side of the circulation, large drops in
Rsys are observed at the same time large increases in
RVEI are seen (Figure 7) for pigs 1 and 2, indicating
that the loss of systemic vascular tone maybe a contri-
buting factor to the volume imbalance in the ventricles.
Discussion
Modeling errors
In response to a pathological challenge, clinically and
physiologically model-based hemodynamic metrics typi-
cally change by 50-100% and in some cases up to 400%.
Nearly all the errors associated with the model outputs
are less than 25% (Table 1), indicating that the subject-
specific models are identified with sufficient accuracy to
identify induced disease states. The larger errors in
Table 1 result from differences between the measured
left and right ventricle stroke volumes, which are
expected to be same at steady state. In some cases, espe-
cially pigs 1 and 2, the ratio of the left to right ventricu-
lar outputs is greater than 2:1. This discrepancy is
probably due to difficulties in measuring the right ven-
tricle volume due to its complex shape, which causes
the model to underestimate the end diastolic volumes
and maximum pressure of the left ventricle and overes-
timate the end diastolic volume and maximum pressure
of the right ventricle. However, the ratio of the mea-
sured stroke volumes is generally consistent for each pig
for the duration of the trial resulting in systematic
errors in the model outputs, so importantly, changes in
the model trends are preserved.
The variation in shape and difference in phase of the
modeled outputs compared with the measured wave-
forms (Figures 3 and 4) are due to the lumped para-
meter nature of the model and errors in the
approximated driver functions (driL and driR) used to
describe the myocardial contraction.
Detecting pulmonary embolism
The main hemodynamic consequence of APE is a block-
age in the pulmonary vasculature leading to the lungs,
resulting in increased pulmonary afterload. Afterload is a
combination of the simple relationship between the mean
arterial pressure and total flow across the system and the
more complex relationships due to the pulsatile and wave
Figure 5 Identified subject-specific pulmonary resistance (Rpul)
during the porcine trials (top) and mean Rpul compared with
the experimentally derived pulmonary vascular resistance [23]
(bottom).
Figure 6 Identified subject-specific maximum right ventricular
pressure (Prv, max) during the porcine trials (top) and mean Prv,
max compared to the measured maximum right ventricular
pressure (bottom).
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reflective nature of circulatory flow. In addition, in the pul-
monary circulation, afterload has an added component
due gravitational effects in lung and the collapsible nature
of alveoli capillaries. It has been recognized in recent
times that pulmonary vascular resistance (PVR which is
the same as Rpul) is not the ideal measure of pulmonary
afterload [34,35], because it does not consider all of these
components of afterload. Furthermore, Rpul in the model
is calculated by assuming pulmonary vein pressure is the
downstream pressure, although may not be the case in
certain scenarios. However, PVR is still the most widely
used clinical metric of pulmonary afterload due to its rela-
tive ease of measurement and lack of widely accepted
alternative. Hence, in this research Rpul was used to track
changes in pulmonary afterload resulting from the inserted
emboli.
Through identifying subject-specific models for each
pig, pulmonary vascular resistance (Rpul) was tracked.
Figure 5 shows the predicted Rpul for each pig across
the duration of the trials. In all five pigs, Rpul increased
during the trials, indicating the presence of a pulmonary
vascular obstruction, as expected. However, note that
Rpul drops for most pigs at the end of the trials as CO
begins to fall significantly.
Figure 5 shows the model tracking changes in the
experimentally derived mean pulmonary vascular resis-
tance calculated for the pigs using a four element
Figure 7 Identified right ventricular expansion index (RVEI,
defined as RVEDV/LVEDV) during the porcine trials (top) and
comparison of the modeled to measured mean RVEI (bottom).
Figure 8 Identified subject specific right ventricle end systolic elastance (Ees, rvf, top left) and systemic resistance (Rsys, top right)
during the porcine trials, along with the mean modeled Ees, rvf (bottom left) and Rsys (bottom right).
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windkessel model [23]. The model appears to systemi-
cally produce larger resistances compared to the
experimentally derived parameters. However, more
importantly, the models track the averaged experimen-
tal trends with a correlation of R2 = 0.81. The model
also reveals sharp increases in pulmonary vascular
resistance caused from the insertion of autologous
blood clots at 120 and 240 minutes into the trials, as
expected and illustrated in Figure 5. These results indi-
cate this approach can capture clinically relevant
change in pulmonary vascular resistance, a major indi-
cator of APE.
Autonomous reflex responses
The condition of a critically ill patient can be deter-
mined by how well their autonomous cardiovascular
reflex responses control circulatory state. In the porcine
trials, each pig’s condition can be analyzed through how
effectively their CVS adapts to the pulmonary embolism
or emboli. One consequence of a blockage in the pul-
monary vasculature is an accumulation of blood
upstream of the obstacle resulting in less flow to left
heart. To compensate, the CVS responds in two main
ways: 1) by increasing systemic vascular resistance, Rsys
[36]; and 2) by strengthening the contractility of the
right heart, Ees,rvf [25].
In the model, Rsys increases to stop flow leaving the
systemic circulation to maintain preload on the left ven-
tricle, whereas Ees, rvf rises to push blood through the
more resistant pulmonary system to avoid accumulation
of volume upstream of the embolism and to prevent the
right heart from overdistending. Figure 8 shows the
modeled Rsys increasing initially followed by a sudden
decrease for pigs 1 and 2, indicating a loss of autono-
mous control. The model also captures sharp increases
in right ventricle contractility (Ees, rvf) after the insertion
of autologous blood clots at 120 and 240 minutes into
the trials (Figure 8). This latter response indicates that
the pigs autonomously maintain hemodynamic stability.
However, failure of Ees, rvf to fully counteract increases
in Rpul has an eventual negative impact, as seen at the
end of the pig 1 trial, where a large drop CO is noticed
as Ees, rvf drops dramatically. These two examples show
how this model-based approach can be used to reveal
the magnitude of the subject’s natural response to the
emboli that can help distinguish how the subject is cop-
ing with the disease state. In a clinical environment,
these parameters also could be monitored to observe
what effect drugs, such as vasopressors and inotropes,
are having on the patient.
Severity of pulmonary embolism
The joint response of Ees, rvf and Rsys attempts to pre-
vent a leftward shift in the intraventricular septum
wall, which would reduce the stressed volume in the
left ventricle and therefore compromise left heart func-
tion. The right ventricle expansion index (RVEI),
defined as the ratio of the right to left end diastolic
volumes, acts as an indicator of how well an indivi-
dual’s autonomous reflex responses are handling the
effects of APE [19,32,33]. When the reflex responses
can no longer preserve homeostasis in the CVS, the
RVEI will increase dramatically as the intraventricular
septum pushes into the left ventricle volume. The pre-
load on the left ventricle will be reduced and CO will
drop as a result [37]. Hence, RVEI describes how well
the subject’s natural reflexes are counteracting the det-
rimental effects of APE.
Averaged across all five pigs, the identified RVEI com-
pared well with the true RVEI with a correlation coeffi-
cient of R2 = 0.92. Figure 7 shows that the modeled
RVEI increases in all the trials, with sharp increases
noticed for pigs 1 and 2 near the end of their trials,
indicating that they are in a near-death state. Whereas
only minor increases (< 25%) are noticed for pigs 3, 4,
and 5, which survive the trials. Hence, the modeled
RVEI provides a good indication of how well the pigs
are coping with APE.
Limitations
The main limitation of model identification method is
its reliance on knowing the pulmonary artery pressure,
which is not widely measured. The use of the pulmon-
ary artery catheter (PAC) has gone out of fashion in
recent times, because it has been found to have little or
even deleterious effects on mortality rates [38-41]. Some
investigators [41] have suggested the use of the PAC by
itself may not be the problem. Instead, incorrect inter-
pretation of the waveform and the use of suboptimal
therapies triggered from data obtained from the PAC
may be the cause of the poorer outcomes. In such cases,
patient-specific models could be used to standardize
interpretation of the measurement. Features of the pul-
monary artery waveform in conjunction with other mea-
surements can be converted into easy to understand
metrics representing ventricular contractility, preload,
vascular stiffness, and resistance, which are directly con-
trollable with current clinical treatments (fluid resuscita-
tion, inotropes, vasopressors, and vasodilators),
providing a better platform for therapy to be based
from. Given the potential, and only small added risks
associated with the PAC [42-47], this compromise favors
improved patient outcome, as well as ease of use. Alter-
natively, the model identification method could easily be
adapted to use echocardiography measurements to iden-
tify parameters of the pulmonary circulation, although
this would reduce the frequency at which the CVS mod-
els could be identified.
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Other limitations of this technique are due to the
lumped parameter nature of the computer CVS model
and the limited number measurements typically avail-
able in the ICU. The lumped parameter nature of the
model restricts this technique from identifying highly
localized changes along the circulation. However, as
seen with APE, the effect of a major localized dysfunc-
tion normally manifest itself on the whole circulation
and therefore can be identified.
The small number of measurements available in the
ICU restricts the number of parameters that can be
identified. Therefore, slow changing parameters, or para-
meters that have lesser effect on the circulation in the
computer model, are held constant so that changes in
more physiologically relevant and sensitive parameters
can be tracked. For example, in the model the left ven-
tricle zero pressure volume (V0, lvf) is not identified and
is fixed as it remains relatively constant in the absence
of major inotropic or loading interventions. By fixing V0,
lvf the more important end systolic left ventricle ela-
stance (Ees, lvf) can be identified and changes in this
parameter can be tracked. Finally, although this process
is restrictive, it enables an approach that requires no
added invasive measurements.
Conclusions
The computer models of the CVS correctly estimated
the known physiological responses to APE. An increase
in Rpul, the main hemodynamic consequence of APE,
related well to the experimentally derived pulmonary
vascular resistance. The individualized models also cap-
tured a loss of autonomous control of important reflex
responses, Rsys and Ees, rvf, in pigs 1 and 2, leading to
cardiovascular failure. Furthermore, the identified RVEI
increased as emboli were inserted into the pigs, indicat-
ing a leftward shift in the intraventricular septum, which
accurately matched the changes in the measured RVEI.
These results clearly show that subject-specific models
can be used to identify clinically useful and relevant car-
diac and circulatory information in acute CVS dysfunc-
tion by accurate regular assessment of (model-based)
subject-specific CVS status. Hence, this research demon-
strates and proves the clinical relevance, concept, and
potential of this model-based approach to CVS monitor-
ing and diagnosis.
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